← All trials
NCT05081297
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 2, 2020
- Primary completion
- Oct 30, 2020
- Completion date
- Oct 31, 2020
- First posted
- Oct 18, 2021
- Last posted
- Oct 18, 2021
- Enrollment
- 40
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PortoLead sponsor
- University of PortoReponsible party - principal investigator
- Instituto de Ciências Biomédicas Abel SalazarStudy director
- Instituto de Ciências Biomédicas Abel SalazarOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.